MedTrace Logo

Methylglyoxal Evaluation in Humans

NCT05350553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2025-04-04

No results posted yet for this study

Summary

The investigators will test the hypothesis that patients with low back pain associated with lumbar disc aberrancy will have elevated MGO-protein levels circulating in the blood that are comparable to patients with painful diabetic neuropathy.

Conditions

  • Type 2 Diabetes
  • Neuropathy, Painful
  • Chronic Low-back Pain
  • Lumbar Disc Herniation

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Doug Wright, PhD · University of Kansas Medical Center

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2025-04-01
Completion
2025-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05350553 on ClinicalTrials.gov